AU2001291172A1 - Methods for the diagnosis of neoplastic disorders using angiogenin - Google Patents

Methods for the diagnosis of neoplastic disorders using angiogenin

Info

Publication number
AU2001291172A1
AU2001291172A1 AU2001291172A AU9117201A AU2001291172A1 AU 2001291172 A1 AU2001291172 A1 AU 2001291172A1 AU 2001291172 A AU2001291172 A AU 2001291172A AU 9117201 A AU9117201 A AU 9117201A AU 2001291172 A1 AU2001291172 A1 AU 2001291172A1
Authority
AU
Australia
Prior art keywords
angiogenin
diagnosis
methods
neoplastic disorders
neoplastic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001291172A
Inventor
James W. Fett
Karen A. Olson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard College
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College filed Critical Harvard College
Publication of AU2001291172A1 publication Critical patent/AU2001291172A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/515—Angiogenesic factors; Angiogenin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU2001291172A 2000-09-20 2001-09-20 Methods for the diagnosis of neoplastic disorders using angiogenin Abandoned AU2001291172A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23438600P 2000-09-20 2000-09-20
US60/234,386 2000-09-20
PCT/US2001/029531 WO2002025286A2 (en) 2000-09-20 2001-09-20 Methods for the diagnosis of neoplastic disorders using angiogenin

Publications (1)

Publication Number Publication Date
AU2001291172A1 true AU2001291172A1 (en) 2002-04-02

Family

ID=22881170

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001291172A Abandoned AU2001291172A1 (en) 2000-09-20 2001-09-20 Methods for the diagnosis of neoplastic disorders using angiogenin

Country Status (3)

Country Link
US (1) US20020055117A1 (en)
AU (1) AU2001291172A1 (en)
WO (1) WO2002025286A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1158985B1 (en) 1999-01-13 2011-12-28 Bayer HealthCare LLC OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
EP1478358B1 (en) 2002-02-11 2013-07-03 Bayer HealthCare LLC Sorafenib tosylate for the treatment of diseases characterized by abnormal angiogenesis
US9704154B2 (en) * 2002-10-01 2017-07-11 World Award Academy, World Award Foundation, Amobilepay, Inc. Wearable personal digital device for facilitating mobile device payments and personal use
US9811818B1 (en) * 2002-10-01 2017-11-07 World Award Academy, World Award Foundation, Amobilepay, Inc. Wearable personal digital device for facilitating mobile device payments and personal use
CA2526636C (en) 2003-05-20 2012-10-02 Bayer Pharmaceuticals Corporation Diaryl ureas for diseases mediated by pdgfr
KR101794225B1 (en) * 2013-09-23 2017-11-08 중앙대학교 산학협력단 Pharmaceutical composition for treatment of corneal endothelial wounds containing angiogenin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966849A (en) * 1985-09-20 1990-10-30 President And Fellows Of Harvard College CDNA and genes for human angiogenin (angiogenesis factor) and methods of expression
JPH0371058A (en) * 1989-08-10 1991-03-26 Tosoh Corp Method for measuring angiogenine
AU6560398A (en) * 1997-03-14 1998-09-29 Endowment for Research in Human Biology, Inc., The Angiogenin receptor, compositions and methods related thereto
AU6578298A (en) * 1997-03-21 1998-10-20 President And Fellows Of Harvard College Antisense inhibition of angiogenin expression

Also Published As

Publication number Publication date
US20020055117A1 (en) 2002-05-09
WO2002025286A2 (en) 2002-03-28
WO2002025286A3 (en) 2002-08-01
WO2002025286A9 (en) 2003-04-03

Similar Documents

Publication Publication Date Title
EP1274354B8 (en) Device for the articulated connection of two bodies
EP1126287A3 (en) Ultrasonic diagnosis apparatus
AU2001275921A1 (en) Pulmonary therapy apparatus
IL155093A0 (en) Morpholin-acetamide derivatives for the treatment on inflammatory diseases
AU2002310044A1 (en) Headwall
AU2001240115A1 (en) Method for the preparation of tetrahydrobenzothiepines
AU2001241903A1 (en) Snow-gliding apparatus
AU2002334870B8 (en) Combinations for the treatment of immunoinflammatory disorders
EP1195130A3 (en) Endoscope apparatus
AU2002219229A1 (en) Means for the diagnosis and therapy of CTCL
AU6910600A (en) Methods for the treatment of mental disorders
AU2002210385A1 (en) Furazanyl-triazole derivates for the treatment of diseases
AU2002231295A1 (en) Developed seed and methods for making the same
AU2001293891A1 (en) New combination for the treatment of asthma
AU2001239510A1 (en) Treatment of renal disorders
AU2001291172A1 (en) Methods for the diagnosis of neoplastic disorders using angiogenin
AU2002327860A1 (en) Diagnostic methods
AU2001247233A1 (en) Ppar gamma agonists for the treatment of liver inflammatory disorders
AU2002258798A1 (en) Methods for the treatment of hepatic disorders
CZ20011872A3 (en) Isonipecotamides for the treatment of integrin-mediated disorders
MXPA03001472A (en) Compounds for the treatment of addictive disorders.
AU2001228878A1 (en) Pupil center determination recorder
AU2002364774A1 (en) Ilk inhibitors for the treatment of renal disease
AU2001245781A1 (en) Cd18-binding antibodies inhibit stenosis-related disorders
AU6079000A (en) Developed seed and methods for making the same